General and Oncologic Surgery
Education
BOARD CERTIFICATION:
– American Board of Surgery – Board Certified
EDUCATION:
– M.D. – Loma Linda University Medical School, Loma Linda, CA
– B.A. – Andrews University, Berrien Springs, Michigan
TRAINING:
– Wayne State University – Surgical Residency, Detroit, MI
Publications
Engraftment of mesothelin chimeric antigen receptor using a hybrid Sleeping Beauty/minicircle vector into NK-92MI cells for treatment of pancreatic cancer.
Batchu RB, Gruzdyn OV, Tavva PS, Kolli BK, Dachepalli R, Weaver DW, Gruber SA.Surgery. 2019 Oct;166(4):503-508. doi: 10.1016/j.surg.2019.05.047. Epub 2019 Aug 13.PMID: 31416604
Perioperative and oncological outcomes of abdominoperineal resection in the prone position vs the classic lithotomy position: A systematic review with meta-analysis.
Mesquita-Neto JWB, Mouzaihem H, Macedo FIB, Heilbrun LK, Weaver DW, Kim S.J Surg Oncol. 2019 Jun;119(7):979-986. doi: 10.1002/jso.25402. Epub 2019 Feb 6.PMID: 30729542
Inhibition of Interleukin-10 in the tumor microenvironment can restore mesothelin chimeric antigen receptor T cell activity in pancreatic cancer in vitro.
Batchu RB, Gruzdyn OV, Mahmud EM, Chukr F, Dachepalli R, Manmari SK, Mostafa G, Weaver DW, Gruber SA.
Surgery. 2018 Mar;163(3):627-632. doi: 10.1016/j.surg.2017.10.056. Epub 2018 Jan 11.PMID: 29336814
Pancreatic Cancer Cell Lysis by Cell-Penetrating Peptide-MAGE-A3-Induced Cytotoxic T Lymphocytes.
Batchu RB, Gruzdyn OV, Qazi AM, Mahmud EM, Mostafa G, Weaver DW, Gruber SA.
JAMA Surg. 2016 Nov 1;151(11):1086-1088. doi: 10.1001/jamasurg.2016.2346.PMID: 27851862 No abstract available.
Enhanced phosphorylation of p53 by microRNA-26a leading to growth inhibition of pancreatic cancer.
Batchu RB, Gruzdyn OV, Qazi AM, Kaur J, Mahmud EM, Weaver DW, Gruber SA.Surgery. 2015 Oct;158(4):981-6; discussion 986-7. doi: 10.1016/j.surg.2015.05.019. Epub 2015 Jul 15.PMID: 26189069